AIMD · Ainos, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Although management expects the Company will continue as a going concern, there is no assurance that management's plans will be successful since the availability and amount of such funding is not certain. Accordingly, substantial doubt exists about the Company's ability to continue as a going concern for at least one year from the issuance of these financial statements.”View the 10-Q filed May 13, 2026
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $18.11K | $124.16K | $20.73K | $122.11K | $3.52M | $594.56K | $16.56K | $11.73K | $77.72K | $250.93K | — | $0 | $0 | $0 | $530 | $58.4K | $5150 | |
| $3776 | $21.25K | $52.6K | $375.85K | $2.11M | $184.18K | $11.28K | $8772 | $64.88K | $60.32K | — | — | — | — | $212 | $4354 | $2943 | |
| $14.34K | $102.91K | -$31.87K | -$253.73K | $1.41M | $410.38K | $5286 | $2959 | $12.85K | $190.61K | — | — | — | — | $318 | $54.04K | $2207 | |
| — | 82.89% | -153.73% | -207.79% | 39.93% | 69.02% | 31.91% | 25.22% | 16.53% | 75.96% | — | — | — | — | 60% | 92.54% | 42.85% | |
| $7.72M | $7.75M | $8.41M | $7.32M | $6.85M | $1.92M | $389 | $52.51K | $32.59K | — | — | — | — | $132.96K | $199.6K | $281.11K | $433.36K | |
| $5.41M | $6.34M | $5.4M | $5.64M | $8.54M | $2.36M | $1.45M | $1.53M | $1.31M | $770.38K | $667.11K | $519.82K | — | $433.19K | $355.33K | $918.81K | $638.16K | |
| — | $4.52M | $4.53M | $4.52M | $4.52M | $2M | $12.88K | $11.66K | $38.3K | $22.77K | $16.69K | $18.49K | $14.52K | $16.12K | $15.53K | $15.29K | — | |
| — | $4.78M | $4.8M | $4.87M | $4.83M | $2.04M | $14.7K | $22.24K | $56.19K | $39.99K | $25.96K | $19.77K | — | $16.12K | $15.57K | $16.6K | $19.85K | |
| $13.13M | $14.09M | $13.81M | $12.95M | $15.38M | $4.28M | $1.45M | $1.58M | $1.35M | $770.38K | — | — | — | — | — | — | — | |
| -$13.11M | -$13.99M | -$13.84M | -$13.21M | -$13.98M | -$3.87M | -$1.44M | -$1.58M | -$1.33M | -$579.76K | -$667.11K | -$519.82K | — | -$566.16K | -$554.61K | -$1.15M | -$1.07M | |
| — | -11268.32% | -66772.17% | -10814.99% | -397.09% | -650.47% | -8696.7% | -13472.11% | -1717.2% | -231.05% | — | — | — | — | -104643.02% | -1962.29% | -20763.38% | |
| — | -$9.21M | -$9.04M | -$8.34M | -$9.14M | -$1.82M | -$1.43M | -$1.56M | -$1.28M | -$539.77K | -$641.16K | -$500.05K | — | -$550.04K | -$539.04K | -$1.13M | -$1.05M | |
| $708.33K | $711.9K | $616.47K | $144.19K | $53.53K | $18.69K | $10.7K | — | $3963 | $37.61K | $2871 | $2053 | — | $103.37K | $155.56K | $211.72K | $93.95K | |
| -$832.81K | -$779.8K | -$1.02M | -$563.35K | -$30.48K | -$21.24K | — | — | — | — | — | — | — | — | — | — | — | |
| -$13.94M | -$14.77M | -$14.86M | -$13.77M | -$14.01M | -$21.24K | -$10.19K | — | — | — | — | — | — | — | — | — | — | |
| — | $800 | $800 | $800 | $0 | — | $0 | $0 | — | — | $0 | $0 | — | — | — | — | — | |
| -$13.94M | -$14.77M | -$14.86M | -$13.77M | -$14.01M | -$3.89M | -$1.45M | -$1.58M | -$1.34M | -$617.38K | -$669.98K | -$521.87K | — | -$622.6K | -$650.85K | -$1.31M | $506.31K | |
| — | -11897.04% | -71702.26% | -11276.98% | -397.96% | -654.04% | -8758.21% | -13479.65% | -1722.3% | -246.04% | — | — | — | — | -122801.32% | -2249.8% | 9831.3% | |
| -$13.94M | -$14.77M | -$14.86M | -$13.77M | — | — | — | — | — | — | — | — | — | -$654.99K | -$681.7K | -$1.33M | $502.11K | |
| -$13.76M | -$14.61M | -$15M | -$13.84M | -$14.21M | -$3.88M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$3.46 | -$7.82 | -$16.80 | — | — | — | — | — | — | — | — | — | — | — | -$7.50 | $3.75 |
| USD/shares | — | -$3.46 | -$7.82 | -$16.80 | — | — | — | — | — | — | — | — | — | -$3.75 | -$3.75 | -$7.50 | $3.75 |
| shares | — | 4.27M | 1.9M | 819.62K | — | 302.05K | 108.62K | 106.39K | 95.05K | 60.44K | 53.72K | 53.72K | — | — | — | 173.41K | 146.78K |
| shares | — | 4.27M | 1.9M | 819.62K | — | 302.05K | 108.62K | 106.39K | 95.05K | 60.44K | 53.72K | 53.72K | — | 195.85K | 195.65K | 173.41K | 151.7K |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 20 similar-size Scientific & Technical Instruments companies (of 40 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2023 |
|---|---|
| COVID-19 Antigen Rapid Test Kits Sales | $33,388 |